Purchase Order 80NSSC24PC325

Award Date 9/11/24
Potential Completion Date 11/25/24
Potential Value $93K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $227,923.88 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and analytical tools. The contract is for the provision of sequencing flow cells and a support plan, to be performed in San Diego, CA. This award does not have a set-aside designation. Illumina has previously secured prime federal contracts and subcontracts with agencies such as the...
This federal contract award is for the purchase of a DNA sequencer by the National Aeronautics and Space Administration (NASA) Ames Research Center. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products, on a firm fixed price basis. The total potential value of the contract is $1,224,258.01, and the completion date is May 31, 2019. The contract is not set aside for any specific business size or socioeconomic category. Illumina is a...
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $202,492.50 firm fixed-price purchase order to Illumina, Inc. for the Illumina NextSeq 1000 sequencing system. This sole-source contract was awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i) since Illumina is the sole provider of the NextSeq 1000 system. The contract has no set-aside designation and will support operations at the NASA Ames Research Center. Illumina is a...
This federal contract award is for the procurement of 12 reagent kits for Illumina's TruSeq Stranded mRNA Library Prep and TruSeq Stranded Total RNA Library Prep sequencing products. The $127,238.22 firm fixed price contract was awarded to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the National Aeronautics and Space Administration (NASA) Shared Services Center. The contract supports the NASA GeneLab project, which aims to increase the...
This federal contract award is for the purchase of reagents by the National Aeronautics and Space Administration (NASA) Shared Services Center. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The firm fixed-price purchase order has a potential value of $142,504.77 and was awarded on June 28, 2019, with a completion date of February 19, 2021. No set-aside designation was used. Illumina has previously been awarded prime federal...
This is a firm fixed price purchase order awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract is for the delivery of reagents with a potential value of $102,251.19 and a completion date of May 26, 2023. The award was made on a sole-source basis under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), as Illumina was determined to be the sole...
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomics analysis instruments and reagents. The $156,933.75 contract provides Illumina sequencing systems, reagents, and support services to the GeneLab, which requires the Illumina sequencers for its daily work. This award is not associated with any set-aside program. Illumina has a history of providing sequencing equipment...
This is a firm fixed price purchase order awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $233,302.47 award is for reagents to support the NASA GeneLab project, which requires various reagents compatible with Illumina sequencing platforms like the NovaSeq 6000 and iSeq 100 for generating sequencing libraries, clusters, and data from biological samples...
The U.S. government agency NASA has awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, for Illumina Service Plans. The contract, valued at $144,114.00, is to provide support services for NASA's GeneLab project, which requires sequencing flow cells and a support plan for the generation of omics data from biological spaceflight experiments. The support plan includes reagent replacement, remote technical...
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $222,744.65 firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of an ILLUMINA NEXTSEQ 1000 SEQUENCER SYSTEM, to be performed in San Diego, CA by June 29, 2022. Illumina has a history of providing sequencing instruments, reagents, and services to support genomic research and analysis...

This federal contract award, valued at $92,922.50, was issued by the National Aeronautics and Space Administration (NASA) Shared Services Center to Illumina, Inc. of San Diego, California. The contract is for the provision of sequencing reagents and flow cells to support genomic sequencing and analysis activities at the NASA Ames Research Center.

The award was made on a sole-source basis under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), as Illumina was determined to be the sole provider of the required products. The contract is a firm-fixed-price purchase order with a period of performance ending on November 25, 2024. There is no set-aside designation associated with this award.

Illumina is a leading manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing such products and services to various federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs.

Generated 3/26/25, 9:45 AM